Literature DB >> 26431293

Current Management of Polypoidal Choroidal Vasculopathy.

Colin S Tan, Tock Han Lim, Seenu M Hariprasad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26431293     DOI: 10.3928/23258160-20150909-02

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


× No keyword cloud information.
  5 in total

1.  Treatment of massive subretinal hemorrhage from polypoidal choroidal vasculopathy and age-related macular degeneration.

Authors:  Colin S Tan; Louis W Lim; Wei Kiong Ngo
Journal:  Int Ophthalmol       Date:  2016-09-26       Impact factor: 2.031

2.  Comparison of Polypoidal Choroidal Vasculopathy Lesion Sizes Measured on Multicolor Imaging and Indocyanine Green Angiography.

Authors:  Louis W Lim; Colin S Tan; Dominic S Ting
Journal:  Transl Vis Sci Technol       Date:  2021-02-05       Impact factor: 3.283

3.  Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy.

Authors:  Zuhua Sun; Yuanyuan Gong; Yating Yang; Ying Huang; Suqin Yu; Junqing Pei; Bing Lin; Rong Zhou; Yingzi Li; Yumin Li; Junyan Zhang; Xiaoling Liu
Journal:  Front Med (Lausanne)       Date:  2022-02-09

4.  Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy.

Authors:  Wei Kiong Ngo; Wai Kitt Chee; Colin S Tan; Tock Han Lim
Journal:  BMC Ophthalmol       Date:  2020-04-15       Impact factor: 2.209

5.  Predictors of persistent disease activity following anti-VEGF loading dose for nAMD patients in Singapore: the DIALS study.

Authors:  Colin S Tan; Louis W Lim; Wei Kiong Ngo; Pandiyan Pannirselvam; Clarence See; Wai Kitt Chee; Nakul Saxena
Journal:  BMC Ophthalmol       Date:  2020-08-06       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.